Athira Pharma, Inc.
Q4 2021 Earnings Call Transcript

Published:

  • Disclaimer*:
    This transcript is designed to be used alongside the freely available audio recording on this page. Timestamps within the transcript are designed to help you navigate the audio should the corresponding text be unclear. The machine-assisted output provided is partly edited and is designed as a guide.
  • Operator:
    00
  • Julie Rathbun:
    00
  • Mark Litton:
    02
  • Hans Moebius:
    05
  • Mark Litton:
    17
  • Operator:
    23
  • Andrew Tsai:
    23
  • Mark Litton:
    24
  • Andrew Tsai:
    24
  • Mark Litton:
    25
  • Hans Moebius:
    25
  • Andrew Tsai:
    26
  • Mark Litton:
    26
  • Hans Moebius:
    26
  • Andrew Tsai:
    28
  • Mark Litton:
    28
  • Operator:
    28
  • Paul Matteis:
    28
  • Hans Moebius:
    29
  • Paul Matteis:
    31
  • Hans Moebius:
    31
  • Mark Litton:
    32
  • Paul Matteis:
    32
  • Mark Litton:
    32
  • Operator:
    32
  • Corinne Jenkins:
    33
  • Hans Moebius:
    33
  • Corinne Jenkins:
    33
  • Mark Litton:
    33
  • Corinne Jenkins:
    34
  • Mark Litton:
    No, no. We will definitely -- we will announce that as we've completed enrollment.
  • Corinne Jenkins:
    34
  • Mark Litton:
    34
  • Operator:
    34
  • Jason Butler:
    34
  • Mark Litton:
    35
  • Hans Moebius:
    35
  • Jason Butler:
    36
  • Hans Moebius:
    37
  • Jason Butler:
    38
  • Mark Litton:
    38
  • Operator:
    38
  • Mark Litton:
    38
  • Operator:
    38